The conversation between human and AI assistant.
How do physicians decide whether to subscribe a new drug/therapy when the expected benefit is unclear and still no HTA-assessment available?
I'm interested in understanding how physicians make the decision to subscribe a new drug or therapy when the expected benefit is unclear and there is no HTA-assessment available.
That's a great question! Generally, physicians will consider a wide range of factors when deciding whether a new drug or therapy is right for their patient. These factors might include the patient's medical history, the potential side effects of the treatment, and the overall effectiveness of the treatment.